Clinical Trials Logo

Clinical Trial Summary

This small, randomized, double blind, placebo controlled pilot study is aimed at determining the effects of oral Immulina dietary supplementation on specific immune biomarkers in the blood.


Clinical Trial Description

This small, randomized, double blind, placebo controlled pilot study is aimed at determining the effects of four weeks of daily Immulina dietary supplementation (800 mg/day) versus four weeks of daily placebo on natural killer (NK) cell numbers and/or natural killer (NK) cell activity in human peripheral blood mononuclear cells collected from human research participants who meet the trial's inclusion/exclusion criteria. ;


Study Design


Related Conditions & MeSH terms

  • Effects of Immulina on Natural Killer Cells

NCT number NCT04071730
Study type Interventional
Source University of Mississippi Medical Center
Contact
Status Completed
Phase N/A
Start date September 3, 2019
Completion date March 11, 2021